1-7 of 7
Lorenza Borin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-Risk Population Screening for Gaucher Disease: Final Results and Key Learnings from an Italian Multicenter Observational Study

Irene Motta, MD, Christian Benedetto, Marina Stroppiano, Elena Cassinerio, MD, Dario Consonni, MD, Lorenza Borin, MD, Paola Ranalli, MD, Wilma Barcellini, Maria Domenica Cappellini, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-141527
Published: 2020
Journal Articles

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Andrew H. Wei, MBBS, FRACP, FRCPA, PhD, Hartmut Döhner, MD, Christopher Pocock, MBBS, Pau Montesinos, MD PhD, Boris Afanasyev, MD DSci, Hervé Dombret, MD, Farhad Ravandi, MD, Hamid Sayar, MD MSc, Jun Ho Jang, MD PhD, Kimmo Porkka, MD, Dominik Selleslag, MD, Irwindeep Sandhu, MD, Mehmet Turgut, MD, Valentina Giai, MD, Yishai Ofran, MD, Merih Kizil Cakar, MD, Aida Botelho de Sousa, MD, Justyna Rybka, MD PhD, Chiara Frairia, MD, Lorenza Borin, MD, Germana Beltrami, MD, Jaroslav Cermak, MD PhD, Gert J. Ossenkoppele, MD PhD, Ignazia La Torre, MD, Barry Skikne, MD, Keshava Kumar, PhD, Qian Dong, DrPH, CL Beach, PharmD, Gail J. Roboz, MD
Journal: Blood
Blood (2019) 134 (Supplement_2): LBA-3.
https://doi.org/10.1182/blood-2019-132405
Published: 2019
Journal Articles

Jak-2 and Nfkbia G ene Expression Play a Strategic Role in Chronic Myeloid Leukemia (CML) Molecular Response during Early Nilotinib Treatment: The PhilosoPhi34 Data

Ester Pungolino, Mariella D'adda, MD, Alessandra Trojani, PhD, Alessandra Perego, MD, Chiara Elena, MD, Alessandra Iurlo, Simona Malato, MD, Mauro Turrini, MD, Gabriella De Canal, PhD, Lorenza Borin, MD, Milena Lodola, PhD, Marianna Caramella, MD, Salvatore Artale, MD, Francesco Spina, MD, Maria Luisa Latargia, MD, Michela Anghilieri, MD, Pierangelo Spedini, MD, Mariacristina Carraro, Barbara Di Camillo, Doriana Gramegna, MD, Maria Luisa Pioltelli, MD, Giuseppe Rossi, MD, Enrica Morra, MD, Roberto Cairoli
Journal: Blood
Blood (2018) 132 (Supplement 1): 5118.
https://doi.org/10.1182/blood-2018-99-113273
Published: 2018
Journal Articles

Clinical Implications of TP53 Mutations and p53 Dysfunction in Patients with Myelodysplastic Syndrome (MDS). a Study from the Italian MDS Clinical Network

Marianna Rossi, MD, Giorgio Croci, Emanuela Boveri, Umberto Gianelli, Maurilio Ponzoni, MD, Laura Giordano, Marta Ubezio, MD, Erica Travaglino, Lucio Morabito, Chiara Milanesi, Elena Saba, Lorenza Borin, MD, Massimo Bernardi, Valeria Santini, MD, Maria Teresa Voso, MD, Susanna Fenu, Attilio Orazi, MD, Armando Santoro, MD, Andrea Bacigalupo, MD, Alessandro Rambaldi, MD Prof, Matteo Giovanni Della Porta, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2959.
https://doi.org/10.1182/blood.V130.Suppl_1.2959.2959
Published: 2017
Journal Articles

The REL-Protocol PhilosoPhi34 - an Open Label, Single Arm, Phase II Study of Nilotinib 300 Mg BID in Newly Diagnosed Chronic Phase Chronic Myeloid Leukaemia (CML) Patients - Confirms Early Clearance of Bone Marrow CD34+/Lin-Ph+ Cells

Ester Pungolino, MD, Gabriella De Canal, Mariella D'adda, MD, Alessandra Perego, MD, Mauro Turrini, MD, Ester Maria Orlandi, MD, Alessandra Trojani, PhD, Lorenza Borin, MD, Alessandra Iurlo, MD, Maria Luisa Latargia, MD, Simona Malato, MD, Maria Cristina Carraro, MD, Stefania Brusorio, Chiara Elena, MD, Francesco Spina, MD, Milena Lodola, Salvatore Artale, MD, Michela Anghilieri, MD, Cristina Bucelli, MD, Maria Luisa Pioltelli, MD, Silvia Cantoni, MD, Giuseppe Rossi, MD, Enrica Morra, MD, Roberto Cairoli, MD
Journal: Blood
Blood (2016) 128 (22): 3080.
https://doi.org/10.1182/blood.V128.22.3080.3080
Published: 2016
Journal Articles

REL-Protocol PhilosoPhi34: An Open Label, Single Arm, Phase II Study of Nilotinib 300 Mg BID in Newly Diagnosed Chronic Phase Chronic Myeloid Leukaemia Patients, to Study the Disappearance of CD34+/Lin-Ph+ Cells from Bone Marrow during Treatment. Preliminary Data

Ester Pungolino, MD, Giuseppe Rossi, MD, Maria Angela Mura, Alessandra Perego, MD, Ester Maria Orlandi, MD, Mauro Turrini, MD, Lorenza Borin, MD, Maria Adele Capucci, MD, Alessandra Iurlo, MD PhD, Alessandra Trojani, PhD, Mariella D'Adda, MD, Francesco Spina, MD, Gabriella De Canal, Maria Luisa Pioltelli, Maria Luisa Latargia, MD, Sergio Pauli, MD, Chiara Elena, MD, Stefania Brusorio, Francesco Lanza, MD, Simona Malato, MD, Michela Anghilieri, MD, Maria C Carraro, MD, Enrica Morra, MD, Roberto Cairoli, MD
Journal: Blood
Blood (2015) 126 (23): 1597.
https://doi.org/10.1182/blood.V126.23.1597.1597
Published: 2015
Journal Articles

Health-Related Quality Of Life In Transfusion-Dependent Patients With Myelodysplastic Syndromes Treated With Deferasirox. A Multicenter Prospective Study

Fabio Efficace, Valeria Santini, Giorgio La Nasa, MD, Francesco Cottone, Carlo Finelli, Lorenza Borin, MD, Giulia Quaresmini, MD, Anna Di Tucci, Antonio Volpe, MD, Daniela Cilloni, Giovanni Quarta, MD, Grazia Sanpaolo, Flavia Rivellini, MD, Flavia Salvi, MD, Alfredo Molteni, Daniele Vallisa, MD, Sergio Storti, Maria Teresa Voso, M.D., Giuliana Alimena, MD, Susanna Fenu, Marco Vignetti, Franco Mandelli, MD, Emanuele Angelucci
Journal: Blood
Blood (2013) 122 (21): 2980.
https://doi.org/10.1182/blood.V122.21.2980.2980
Published: 2013